ZNF471 and gastric cancer: After adjustment of gender and TNM stage, hypermethylation of ZNF471 promoter (median value) was associated with poorer survival of gastric cancer patients (HR 2.315; 95% CI: 1.307–4.099; P = 0.004) (Table 1).